News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Giuseppe Caruso: TOO is an easy-to-use composite quality measure that is associated with survival in advanced-stage ovarian cancer
Giuseppe Caruso/X
Oct 11, 2024, 14:34

Giuseppe Caruso: TOO is an easy-to-use composite quality measure that is associated with survival in advanced-stage ovarian cancer

Giuseppe Caruso, Gynecology Oncology Specialist at European Institute of Oncology, shared a post a post on X:

“Textbook oncologic outcome (TOO) is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer.”

Tittle: Textbook oncologic outcome is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer

Authors: Giuseppe Carusoa,b, Carrie L. Langstraata, Amanika Kumara, Michaela E. McGreec, Angela J. Foughtc, Dimitrios Nasioudisd, Giovanni D. Alettib, Nicoletta Colombob, Robert L. Giuntolid and William A. Cliby

Giuseppe Caruso: TOO is an easy-to-use composite quality measure that is associated with survival in advanced-stage ovarian cancer

advanced-stage ovarian cancer Amanika Kumara Angela J. Foughtc b cancer Carrie L. Langstraata Giuseppe Caruso Giuseppe Carusoa Michaela E. McGreec Nicoletta Colombob OncoDaily Oncology Ovarian Cancer Robert L. Giuntolid Textbook oncologic outcome William A. Cliby
Special Coverage
Blog
Dec 19, 2024, 02:54
Bladder-Sparing Strategies for MIBC: Insights from Professor Ming Cao at ESMO Asia2024
Blog
Dec 19, 2024, 02:52
Vicki Kennedy: The critical importance of psychosocial oncology standards
Blog
Dec 19, 2024, 02:47
Liver cancer treatment through radioembolization - IMAGIO
Blog
Dec 19, 2024, 02:43
Paolo Tarantino: The highly awaited Breast Cancer trials with positive results
Blog
Dec 19, 2024, 02:34
Javier Muñoz Carrillo: First-hand presentation of cutting-edge clinical trial results in breast cancer research at SABCS24
Science
Dec 19, 2024, 02:31
Laura Bukavina: Use of Perioperative Immunotherapy and TKI in RCC with IVC thrombus patients by Kotaro Suzuki et al.
Science
Dec 19, 2024, 02:26
Nicholas Hornstein: CtDNA for Appendiceal Adenocarcinoma is not as robust as in Colorectal Cancer
Blog
Dec 19, 2024, 02:20
Sathgen Therapeutics Named Company of the Year 2024 by Silicon India Magazine
Blog
Dec 19, 2024, 02:19
Cancer costs the average patient in Canada nearly $33,000 in their lifetime - Canadian Cancer Society
Blog
Dec 19, 2024, 02:17
Living with Blood Cancer makes time precious and more urgent - The Leukemia and Lymphoma Society
Blog
Dec 19, 2024, 02:16
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research - NCI Division of Cancer Prevention
Blog
Dec 19, 2024, 02:11
An upcoming FDA-AACR workshop on DPD deficiency testing